SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
BioSpecifics Technologies Corporation Announces Presentation of Additional Phase III Data from XIAFLEX® Clinical Trials for Peyronie's Disease at SMSNA/ISSM Joint Annual Meeting